AzTrials
AzTrials

Chronic Perineal PainNCT07117019

Effect of Myofascial Release Combined With Acupressure on BL23 On Chronic Perineal Pain

A study testing Self-care and lifestyle intervention advice, Myofascial release and Acupressure in people with Chronic Perineal Pain, run by Cairo University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aims to determine the effect of the myofascial release combined with acupressure on BL23 on chronic perineal pain. Read more about this study

Who is it for?
Ages 18 to 30 years, women onlyHealthy volunteers can take part
Conditions the study is for
Chronic Perineal Pain
What is being tested?
Self-care and lifestyle intervention advice, Myofascial release and Acupressure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteEgypt
Study dates
12 Aug 2025to 26 Oct 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 30 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • All women will be diagnosed with chronic perineal pain from episiotomy scar and referred by the gynecologist.
  • Their age will range from 18 to 30 years.
  • They should not have skin irritation/inflammation at the perineum.
  • They should not receive epidural anesthesia, ice packs, or non-steroidal anti-inflammatory drugs during the treatment sessions.
  • They should not suffer from major physical problems such as spinal fractures or disc Hernias.

Who cannot join

  • Having a laceration other than an episiotomy.
  • Having an operative vaginal delivery (forceps, vacuum).
  • Chronic disease (diabetes mellitus, thyroid, hypertension).
  • Regular medication use or any postnatal complication in the newborn.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Cairo University

    Giza

Other trials in Egypt

About this study

This study aims to determine the effect of the myofascial release combined with acupressure on BL23 on chronic perineal pain.

Read the detailed description

Perineal pain is a typical sequel vaginal delivery, affecting up to 42% of women at ten days postpartum and persisting in 10% at 18 months. As the fibers of scar tissue form, however, they are typically weaker, with more limited movement and less oxygen circulation than normal skin tissue. This lack of skin and muscle elasticity around an episiotomy or perineal scar can result in side effects, such as pain during sex or when passing a stool, urinary or fecal incontinence, pelvic organ prolapse, and ongoing infections. Moreover, chronic perineal pain can affect the woman psychologically and impact the transition to parenthood, the sexual relationship with her partner, and their ability to breastfeed.

Pharmacological therapies are effective; however, they have side effects as they can pass into breast milk and subsequent harm to the neonate. So, studies need to test and support the effectiveness and safety of some non-pharmacological techniques that could benefit a wide range of women suffering from postpartum perineal pain.

Perineal massage enhances perineal results by stretching the tissues of the vagina, facilitating perineal relaxation, and increasing tissue circulation. Acupressure is a noninvasive method whose nature is similar to acupuncture. This method is effective in sedating pain and reducing its intensity. Some researchers believe that acupressure prevents the transfer of pain stimulators, increases blood endorphin levels, and reduces pain.

Therefore, this study will be carried out to verify the effect of myofascial release and acupressure on postpartum perineal pain.

To our knowledge, this study is the first to investigate the effect of myofascial release combined with acupressure on chronic postpartum perineal pain. Therefore, this study will be conducted to provide physiotherapists with updated scientific knowledge concerning the effect of adding the myofascial release to acupressure on chronic perineal pain, aiming to improve quality of life and decrease pain. This study may expand the role of physiotherapy in women's health.

Being tested
Self-care and lifestyle intervention advice, Myofascial release, Acupressure

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Self-care and lifestyle intervention adviceOther

    All females in both groups will follow self-care and lifestyle advice for 4 weeks.

  • Myofascial releaseOther

    Females in the experimental group will receive intravaginal myofascial release in lithotomic position. After ensuring empty bladder/bowel, therapist uses sterile gloves and lubricant to insert fingers 2-3cm into vagina, pressing vaginal walls bilaterally for 2 minutes. Perineal massage follows, targeting scar tissue and tender points with friction at right angles. Treatment duration starts at 5 minutes (due to pain tolerance) and gradually increases to 20 minutes. Hot pack or ultrasound may be used pre-treatment for pain relief. Therapist performs gentle U-shaped reciprocating massage movements up and down towards rectum for 20 minutes total. Sterile technique maintained throughout with hand washing and glove changes between procedures.

  • AcupressureOther

    Each female in the experimental group will receive acupressure on BL 23 as follows: Acupressure is also another branch of acupuncture. In this method, fingers press the key points on the skin to stimulate and induce the body's natural self-healing capabilities. In the present study, the BL23 point located 1.5 cm lateral to the lower border of the spinous process of the second lumbar vertebra was employed.

    The therapist will apply pressure on BL 23 points with the thumb for 5 minutes in the counterclockwise direction. In the second 5 minutes, pressure was applied in the opposite direction for 5 minutes. Similarly, the pressure was continued for 20 minutes.

Study groups in NCT07117019
Study groupRoleWhat they receive
Self-care and lifestyle intervention adviceActive comparatorIt will include 20 women suffering from chronic postpartum perineal pain. They will receive self-care and lifestyle intervention advice for four weeks during their daily lifestyle routine.
Receives: Other: Self-care and lifestyle intervention advice
Self-care and lifestyle intervention advice + Myofascial release + AcupressureExperimentalIt will include 20 women suffering from chronic postpartum perineal pain. They will receive the same advice as in the experimental group in addition to myofascial release and acupressure on the BL23 point, three sessions per week for four weeks. The duration of the session will be 40 minutes.
Receives: Other: Self-care and lifestyle intervention advice; Other: Myofascial release; Other: Acupressure

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Assessment of intensity of perineal pain

    The McGill Pain Questionnaire assesses subjective pain experience through three major word descriptor classes: sensory, affective, and evaluative, plus an intensity scale. It provides three quantitative measures: (1) Pain Rating Index (PRI) - based on rank values where words implying least pain=1, increasing sequentially. Separate scores calculated for sensory (subclasses 1-10), affective (11-15), evaluative (16), and miscellaneous (17-20) categories, plus total score (1-20). (2) Number of Words Chosen (NWC) - total descriptors selected. (3) Present Pain Intensity (PPI) - number-word combination indicating overall pain intensity at administration time using 1-5 scale. Designed for statistical analysis of clinical pain.

    Measured: 4 weeks

Secondary outcomes (2)
  1. Assessment of the quality of the scar

    The Patient and Observer Scar Assessment Scale (POSAS) is a dual-component tool for evaluating scars. The Observer Scale rates 5 variables (vascularity, pigmentation, thickness, relief, pliability, surface area) using 10-point scoring, totaling 5-50 points. The Patient Scale assesses 6 items (pain, itching, color, stiffness, thickness, irregularity) also using 10-point scoring, totaling 6-60 points. Lower scores indicate normal skin. POSAS demonstrates superior internal consistency and inter-observer reliability compared to the Vancouver Scar Scale, with the unique advantage of incorporating patient subjective assessments alongside objective clinical observations, making it ideal for comprehensive post-surgical scar evaluation.

    Measured: 4 weeks

  2. Assessment of quality of life

    The EuroQol five-dimensional (EQ-5D) is a generic preference-based instrument measuring health-related quality of life across five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has three response levels (1=no problem, 2=moderate problem, 3=severe problem). These can be converted into a summary index score with maximum value of 1 (best health state). Additionally, it includes a visual analogue scale (VAS) rating general health status from 0-100, where 100 represents optimal health. The EQ-5D is widely used for creating health profiles and calculating utility values for economic evaluations.

    Measured: 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Aug 2025
  2. Study start12 Aug 2025
  3. Primary completion12 Oct 2025
  4. Study completion26 Oct 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07117019
Sponsor's protocol ID
P.T.REC/012/005183
Status last verified
Apr 2026
First submitted
5 Aug 2025
Last updated
6 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Self-care and lifestyle intervention advice, Myofascial release and Acupressure in people with Chronic Perineal Pain, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Assessment of intensity of perineal pain (time frame: 4 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in